Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 3721 - 500 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
Reset 

NeuExcell Therapeutics Announces Successful Dosing of First Patient by NeuroD1 Gene Therapy

Read more ››
By: PR Newswire Association LLC. - 22 Mar 2024
Related companies:  NeuExcell Therapeutics Inc.

FDA Approves Nonsteroidal Treatment for Duchenne Muscular Dystrophy

Read more ››
By: PR Newswire Association LLC. - 22 Mar 2024
Related companies:  U.S. Food and Drug Administration

PPMD Applauds FDA for Approval of DUVYZAT™ (Givinostat) for Duchenne Patients Ages Six Years and Older

Read more ››
By: PR Newswire Association LLC. - 22 Mar 2024

Global Subcutaneous Immunoglobulin Market Analysis & Forecast 2024-2034, By Product, Application, End-user and Region

Read more ››
By: PR Newswire Association LLC. - 22 Mar 2024

Global Animal Biotechnology Market Outlook 2024-2029 - Market Sees Increasing Prevalence of Obesity, Inflammation and Cancer in Dogs

Read more ››
By: PR Newswire Association LLC. - 22 Mar 2024

Global OTC Artificial Tears Analysis Report 2023-2030: The Influence of Smart Technologies, Market Positioned for Continued Expansion Amid Growing Focus on Eye Wellness

Read more ››
By: PR Newswire Association LLC. - 22 Mar 2024

DNA Sequencing Market Projected to Reach $210.34 billion by 2030 - Exclusive Report by 360iResearch

Read more ››
By: PR Newswire Association LLC. - 22 Mar 2024

Lyra Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

Read more ››
By: GlobeNewswire - 21 Mar 2024
Related companies:  Lyra Therapeutics, Inc.

Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q4 and FY2023 Financial Results

Read more ››
By: GlobeNewswire - 21 Mar 2024
Related companies:  Dianthus Therapeutics

Nkarta Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights

Read more ››
By: GlobeNewswire - 21 Mar 2024
Related companies:  Nkarta, Inc.

Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights

Read more ››
By: GlobeNewswire - 21 Mar 2024
Related companies:  Journey Medical Corporation

Kineta Reports Full Year 2023 Financial Results and Provides Corporate Update

Read more ››
By: GlobeNewswire - 21 Mar 2024
Related companies:  Kineta, Inc.

Americans with Disabilities Act (ADA) May Protect Physicians Wrongfully Compelled to Have Psychiatric Evaluation, according to Journal of American Physicians and Surgeons

Read more ››
By: GlobeNewswire - 21 Mar 2024

Hyperfine, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results

Read more ››
By: GlobeNewswire - 21 Mar 2024
Related companies:  Hyperfine, Inc.

Asensus Surgical, Inc. Reports Operating and Financial Results for the Fourth Quarter 2023 and Full Year 2023

Read more ››
By: GlobeNewswire - 21 Mar 2024
Related companies:  Asensus Surgical, Inc.

ARS Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results

Read more ››
By: GlobeNewswire - 21 Mar 2024

TELA Bio Achieves Record Fourth Quarter and Full Year 2023 Revenues and Reports Complete Financial Results

Read more ››
By: GlobeNewswire - 21 Mar 2024
Related companies:  TELA Bio, Inc

Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update

Read more ››
By: GlobeNewswire - 21 Mar 2024
Related companies:  BioLight Israeli Life Sciences Ltd. | Bolt Biotherapeutics, Inc.

Xtant Medical to Issue Fourth Quarter and Full Year 2023 Financial Results on April 1, 2024

Read more ››
By: GlobeNewswire - 21 Mar 2024
Related companies:  Xtant Medical

Senti Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Reviews Recent Highlights

Read more ››
By: GlobeNewswire - 21 Mar 2024
Related companies:  Senti Biosciences
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
to the top ↑